Urologic Oncology Group

Luke Thomas Lavallée profile picture

Contact Information

Luke Thomas Lavallée, MDCM, MSc, FRCSC

lulavallee@toh.ca

Administrative Assistant:
Liz Verdon
Phone: 613-737-8899 x 73019
Email: lverdon@toh.ca

The Ottawa Hospital, General Campus
501 ch. Smyth Rd.
Box / C.P. 222
Ottawa, ON
K1H 8L6



ORCID logo https://orcid.org/0000-0001-9286-5965

News

Researchers at The Ottawa Hospital awarded 15 CIHR grants worth more than $8.4 million
February 3, 2023 - Researchers at The Ottawa Hospital are playing a lead role in 14 new projects awarded more than $8 million from the Canadian Institutes of Health Research (CIHR).
Researchers to advance science and improve health with new CIHR funding
February 14, 2019 - Researchers at The Ottawa Hospital, affiliated with the University of Ottawa, are playing a lead role in nine new projects funded by the Canadian Institutes of Health Research (CIHR). These projects will advance science and improve health in ...
Urologists reduce unnecessary prostate cancer surgery in Eastern Ontario
July 5, 2018 - A growing number of patients in Eastern Ontario are being saved from unnecessary prostate cancer surgeries, according to a study led by Dr. Luke Lavallée and Dr. Luke Witherspoon published in CMAJ Open. While prostate cancer is the most common ...
Prostate cancer research gets $200,000 boost from TELUS Ride For Dad
September 21, 2016 - Drs. Christina Addison, Kristopher Dennis, Jim Dimitroulakos and Luke Lavallée were awarded a combined $200,000 from the 2015 TELUS Ride For Dad to study prostate cancer from four different angles. Dr. Lavallée will establish an advanced prostate
$150,000 grant to help researchers test whether exercise before surgery can help elderly patients recover
August 17, 2016 - Dr. Daniel McIsaac and his team were awarded $US 150,000 by the International Anesthesia Research Society to test whether home-based exercise training before cancer surgery can improve the outcomes of frail elderly patients. This population is at
Many prostate cancer patients saved from unnecessary treatments and side effects
February 29, 2016 - Low-risk patients increasingly undergoing regular monitoring rather than immediate treatment Of the approximately 24,000 Canadians diagnosed with prostate cancer each year, about half have a slow-growing form that poses little risk to their he
Controversial prostate cancer screening can be improved by repeating abnormal tests
December 10, 2015 - For more than 20 years, the prostate-specific antigen (PSA) test has been used to help screen for prostate cancer, but in recent years, some task forces have called for this blood test to be abandoned because it leads to many unnecessary biopsies. No